213 related articles for article (PubMed ID: 27935736)
1. Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial.
Viscoli CM; Inzucchi SE; Young LH; Insogna KL; Conwit R; Furie KL; Gorman M; Kelly MA; Lovejoy AM; Kernan WN;
J Clin Endocrinol Metab; 2017 Mar; 102(3):914-922. PubMed ID: 27935736
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Kernan WN; Viscoli CM; Furie KL; Young LH; Inzucchi SE; Gorman M; Guarino PD; Lovejoy AM; Peduzzi PN; Conwit R; Brass LM; Schwartz GG; Adams HP; Berger L; Carolei A; Clark W; Coull B; Ford GA; Kleindorfer D; O'Leary JR; Parsons MW; Ringleb P; Sen S; Spence JD; Tanne D; Wang D; Winder TR;
N Engl J Med; 2016 Apr; 374(14):1321-31. PubMed ID: 26886418
[TBL] [Abstract][Full Text] [Related]
3. Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.
Kernan WN; Viscoli CM; Dearborn JL; Kent DM; Conwit R; Fayad P; Furie KL; Gorman M; Guarino PD; Inzucchi SE; Stuart A; Young LH;
JAMA Neurol; 2017 Nov; 74(11):1319-1327. PubMed ID: 28975241
[TBL] [Abstract][Full Text] [Related]
4. Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone.
Young LH; Viscoli CM; Schwartz GG; Inzucchi SE; Curtis JP; Gorman MJ; Furie KL; Conwit R; Spatz ES; Lovejoy A; Abbott JD; Jacoby DL; Kolansky DM; Ling FS; Pfau SE; Kernan WN;
Circulation; 2018 Sep; 138(12):1210-1220. PubMed ID: 29934374
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus.
Young LH; Viscoli CM; Curtis JP; Inzucchi SE; Schwartz GG; Lovejoy AM; Furie KL; Gorman MJ; Conwit R; Abbott JD; Jacoby DL; Kolansky DM; Pfau SE; Ling FS; Kernan WN;
Circulation; 2017 May; 135(20):1882-1893. PubMed ID: 28246237
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).
Yaghi S; Furie KL; Viscoli CM; Kamel H; Gorman M; Dearborn J; Young LH; Inzucchi SE; Lovejoy AM; Kasner SE; Conwit R; Kernan WN;
Circulation; 2018 Jan; 137(5):455-463. PubMed ID: 29084736
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke.
Kernan WN; Inzucchi SE; Viscoli CM; Brass LM; Bravata DM; Shulman GI; McVeety JC; Horwitz RI
Stroke; 2003 Jun; 34(6):1431-6. PubMed ID: 12730556
[TBL] [Abstract][Full Text] [Related]
8. Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial.
Furie KL; Viscoli CM; Gorman M; Ford GA; Young LH; Inzucchi SE; Guarino PD; Lovejoy AM; Conwit R; Tanne D; Kernan WN;
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):21-27. PubMed ID: 28939682
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.
Inzucchi SE; Viscoli CM; Young LH; Furie KL; Gorman M; Lovejoy AM; Dagogo-Jack S; Ismail-Beigi F; Korytkowski MT; Pratley RE; Schwartz GG; Kernan WN;
Diabetes Care; 2016 Oct; 39(10):1684-92. PubMed ID: 27465265
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Hu K; Xu W; Williams Z
N Engl J Med; 2016 Aug; 375(7):703-4. PubMed ID: 27532848
[No Abstract] [Full Text] [Related]
11. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Doehner W; Anker SD
N Engl J Med; 2016 Aug; 375(7):703. PubMed ID: 27532847
[No Abstract] [Full Text] [Related]
12. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Bursztyn M
N Engl J Med; 2016 Aug; 375(7):702-3. PubMed ID: 27532846
[No Abstract] [Full Text] [Related]
13. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Viscoli CM; Kernan WN; Young LH
N Engl J Med; 2016 Aug; 375(7):704. PubMed ID: 27532845
[No Abstract] [Full Text] [Related]
14. Comparing pioglitazone to insulin with respect to cancer, cardiovascular and bone fracture endpoints, using propensity score weights.
Vallarino C; Perez A; Fusco G; Liang H; Bron M; Manne S; Joseph G; Yu S
Clin Drug Investig; 2013 Sep; 33(9):621-31. PubMed ID: 23881565
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.
Viscoli CM; Brass LM; Carolei A; Conwit R; Ford GA; Furie KL; Gorman M; Guarino PD; Inzucchi SE; Lovejoy AM; Parsons MW; Peduzzi PN; Ringleb PA; Schwartz GG; Spence JD; Tanne D; Young LH; Kernan WN;
Am Heart J; 2014 Dec; 168(6):823-9.e6. PubMed ID: 25458644
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial.
Spence JD; Viscoli CM; Inzucchi SE; Dearborn-Tomazos J; Ford GA; Gorman M; Furie KL; Lovejoy AM; Young LH; Kernan WN;
JAMA Neurol; 2019 May; 76(5):526-535. PubMed ID: 30734043
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance.
Spence JD; Viscoli C; Kernan WN; Young LH; Furie K; DeFronzo R; Abdul-Ghani M; Dandona P; Inzucchi SE
Diabetes Obes Metab; 2022 Jun; 24(6):1150-1158. PubMed ID: 35253334
[TBL] [Abstract][Full Text] [Related]
18. The IRIS (Insulin Resistance Intervention after Stroke) trial: A new perspective on pioglitazone.
Inzucchi SE; Furie KL
J Diabetes; 2016 Sep; 8(5):607-9. PubMed ID: 27125599
[No Abstract] [Full Text] [Related]
19. Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk.
Viscoli CM; Kent DM; Conwit R; Dearborn JL; Furie KL; Gorman M; Guarino PD; Inzucchi SE; Stuart A; Young LH; Kernan WN;
Stroke; 2019 Jan; 50(1):95-100. PubMed ID: 30580725
[TBL] [Abstract][Full Text] [Related]
20. Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study.
Schwartz AV; Chen H; Ambrosius WT; Sood A; Josse RG; Bonds DE; Schnall AM; Vittinghoff E; Bauer DC; Banerji MA; Cohen RM; Hamilton BP; Isakova T; Sellmeyer DE; Simmons DL; Shibli-Rahhal A; Williamson JD; Margolis KL
J Clin Endocrinol Metab; 2015 Nov; 100(11):4059-66. PubMed ID: 26305617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]